NOVEL IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

IMMATICS BIOTECHNOLOGIES GMBH

发明人:

LEWANDROWSKI, PETER,WALTER, STEFFEN,WEINSCHENK, TONI,HILF, NORBERT,TRAUTWEIN, CLAUDIA,SCHOOR, OLIVER,SINGH, HARPREET

申请号：

NZ58282208

公开号：

NZ582822A

申请日:

2008.07.25

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

A peptide comprising a sequence of SEQ ID NO: 1 which can induce T cells to cross-react with the peptide. The peptide can be used in methods to generate cytotoxic T lymphocytes and for treating cancer. The cancer cells can be glioblastoma cells, colorectal, pancreatic, lung, renal or gastric cancer cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/